| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 743399 | Null | 0.0152619242759634 | 0.24261414 |
| NSC 743430 | 2-{4-[4-(4-{4-[6-(4-methyl piperazino)-1H-benzo[d]imidazole-2-yl]phenoxy}butyl)piperazino]butyl}-2,3-dihydro-1H-benzo[de]isoquinoline-1,3-dione | 0.0152619242759634 | 0.25991359 |
| NSC 754385 | 1-[bis(4,4'-aminophenyl)methylidenyl]-[3]ferrocenophane | 0.0152619242759634 | 0.21934223 |
| NSC 80103 | 2,3-Butanediol, 1,4-bis(2-methyl-1-aziridinyl)- (8CI) | 0.0152619242759634 | 0.19033208 |
| NSC 287459 | Cytarabine AY | 0.0152619242759636 | 0.1589847 |
| NSC 39084 | [Methyl(nitroimidazolyl)mercaptopurine] | 0.0152619242759636 | 0.22373037 |
| NSC 629924 | Null | 0.0152619242759636 | -0.033178493 |
| NSC 657989 | 4H-Pyrazolo[3,4-d][1,3]thiazin-6-amine, 1-(2- hydroxybenzoyl)-3-methyl-4-phenyl- | 0.0152619242759636 | 0.22766034 |
| NSC 669229 | 2-trans-n-buten-1-yl-estradiol | 0.0152619242759636 | 0.69815372 |
| NSC 5639 | Null | 0.0170494763533717 | 0.61046433 |